Trastuzumab enhanced the cytotoxicity of Vγ9Vδ2 T cells against zoledronate-sensitized osteosarcoma cells.

MLA

Liu, Meng, et al. “Trastuzumab Enhanced the Cytotoxicity of Vγ9Vδ2 T Cells against Zoledronate-Sensitized Osteosarcoma Cells.” International Immunopharmacology, vol. 28, no. 1, Sept. 2015, pp. 160–67. EBSCOhost, https://doi.org/10.1016/j.intimp.2015.06.002.

APA

Liu, M., Sun, L.-L., Li, Y.-J., Li, H.-Y., Zhang, J., Li, B.-H., & Ye, Z.-M. (2015). Trastuzumab enhanced the cytotoxicity of Vγ9Vδ2 T cells against zoledronate-sensitized osteosarcoma cells. International Immunopharmacology, 28(1), 160–167. https://doi.org/10.1016/j.intimp.2015.06.002

Chicago

Liu, Meng, Ling-Ling Sun, Ying-Jun Li, Heng-Yuan Li, Jian Zhang, Bing-Hao Li, and Zhao-Ming Ye. 2015. “Trastuzumab Enhanced the Cytotoxicity of Vγ9Vδ2 T Cells against Zoledronate-Sensitized Osteosarcoma Cells.” International Immunopharmacology 28 (1): 160–67. doi:10.1016/j.intimp.2015.06.002.